Gadolinium contrast agent-induced CD163+ ferroportin+ osteogenic cells in nephrogenic systemic fibrosis

American Journal of Pathology

Volumn 183, Issue 3, 2013, Pages 796-807

  Swaminathan, Sundararaman ^a,c   Bose, Chhanda ^a,c   Shah, Sudhir V ^a,c   Hall, Kimberly A ^b   Hiatt, Kim M ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; FERROPORTIN; FIBROBLAST GROWTH FACTOR 23; GADODIAMIDE; OSTEOCALCIN; PROCOLLAGEN; TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BONE DEVELOPMENT; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; NEPHROGENIC SYSTEMIC FIBROSIS; OSSIFICATION; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CALCIFICATION, PHYSIOLOGIC; CATION TRANSPORT PROTEINS; CELL DIFFERENTIATION; COLLAGEN; CONTRAST MEDIA; FIBROBLAST GROWTH FACTORS; GADOLINIUM; GADOLINIUM DTPA; HUMANS; LEUKOCYTES, MONONUCLEAR; NEPHROGENIC FIBROSING DERMOPATHY; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PHENOTYPE; RECEPTORS, CELL SURFACE; SKIN; TRANSCRIPTION FACTORS;

EID: 84883186673     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.06.008     Document Type: Article

References (54)

1. T. Grobner Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21 2006 1104 1108
2. S. Swaminathan, T.D. Horn, D. Pellowski, S. Abul-Ezz, J.A. Bornhorst, S. Viswamitra, and S.V. Shah Nephrogenic systemic fibrosis, gadolinium, and iron mobilization N Engl J Med 357 2007 720 722
3. S.E. Cowper, L.D. Su, J. Bhawan, H.S. Robin, and P.E. LeBoit Nephrogenic fibrosing dermopathy Am J Dermatopathol 23 2001 383 393
4. R.D. Swartz, L.J. Crofford, S.H. Phan, R.W. Ike, and L.D. Su Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure Am J Med 114 2003 563 572
5. L. Amuluru, W. High, K.M. Hiatt, J. Ranville, S.V. Shah, B. Malik, and S. Swaminathan Metal deposition in calcific uremic arteriolopathy J Am Acad Dermatol 61 2009 73 79
6. A. Deng, D. Bilu Martin, A. Spillane, J. Chwalek, S. Surin-Lord, S. Brooks, J. Patrali, B. Sina, A. Gaspari, and G. Kao Nephrogenic systemic fibrosis with a spectrum of clinical and histopathological presentation: a disorder of aberrant dermal remodeling J Cutan Pathol 37 2009 204 210
7. Y. Nagai, M. Hasegawa, K. Shinmi, C. Kishi, Y. Tsushima, K. Endo, K. Okabe, K. Suzuki, and O. Ishikawa Nephrogenic systemic fibrosis with multiple calcification and osseous metaplasia Acta Derm Venereol 88 2008 597 600
8. J.P. Weigle, and D.R. Broome Nephrogenic systemic fibrosis: chronic imaging findings and review of the medical literature Skeletal Radiol 37 2008 457 464
9. P. Quatresooz, P. Paquet, T. Hermanns-Lê, and G.E. Piérard Immunohistochemical aspects of the fibrogenic pathway in nephrogenic systemic fibrosis Appl Immunohistochem Mol Morphol 18 2010 448 452
10. M. Girardi, J. Kay, D.M. Elston, P.E. Leboit, A. Abu-Alfa, and S.E. Cowper Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations J Am Acad Dermatol 65 2011 1095 1106
11. S. Swaminathan, W.A. High, J. Ranville, T.D. Horn, K. Hiatt, M. Thomas, H.H. Brown, and S.V. Shah Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis Kidney Int 73 2008 1413 1418
12. G. Corna, L. Campana, E. Pignatti, A. Castiglioni, E. Tagliafico, L. Bosurgi, A. Campanella, S. Brunelli, A.A. Manfredi, P. Apostoli, L. Silvestri, C. Camaschella, and P. Rovere-Querini Polarization dictates iron handling by inflammatory and alternatively activated macrophages Haematologica 95 2010 1814 1822
13. M. Gössl, U.I. Mödder, E.J. Atkinson, A. Lerman, and S. Khosla Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis J Am Coll Cardiol 52 2008 1314 1325
14. D.R. Broome Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting Eur J Radiol 66 2008 230 234
15. L. Helming, and S. Gordon Macrophage fusion induced by IL-4 alternative activation is a multistage process involving multiple target molecules Eur J Immunol 37 2007 33 42
16. A.F. Koreishi, R.M. Nazarian, A.J. Saenz, V.E. Klepeis, A.G. McDonald, A.B. Farris, R.B. Colvin, L.M. Duncan, R.V. Mandal, and J. Kay Nephrogenic systemic fibrosis: a pathologic study of autopsy cases Arch Pathol Lab Med 133 2009 1943 1948
17. D.P. Ruiz-Genao, M.P. Pascual-Lopez, S. Fraga, M. Aragues, and A. Garcia-Diez Osseous metaplasia in the setting of nephrogenic fibrosing dermopathy J Cutan Pathol 32 2005 172 175
18. K. Hershko, C. Hull, L. Ettefagh, S. Nedorost, S. Dyson, T. Horn, and A.C. Gilliam A variant of nephrogenic fibrosing dermopathy with osteoclast-like giant cells: a syndrome of dysregulated matrix remodeling? J Cutan Pathol 31 2004 262 265
19. R.K. Suda, P.C. Billings, K.P. Egan, J.H. Kim, R. McCarrick-Walmsley, D.L. Glaser, D.L. Porter, E.M. Shore, and R.J. Pignolo Circulating osteogenic precursor cells in heterotopic bone formation Stem Cells 27 2009 2209 2219
20. V.Y. Lounev, R. Ramachandran, M.N. Wosczyna, M. Yamamoto, A.D.A. Maidment, E.M. Shore, D.L. Glaser, D.J. Goldhamer, and F.S. Kaplan Identification of progenitor cells that contribute to heterotopic skeletogenesis J Bone Joint Surg Am 91 2009 652 663
21. G.Z. Eghbali-Fatourechi, J. Lamsam, D. Fraser, D. Nagel, B.L. Riggs, and S. Khosla Circulating osteoblast-lineage cells in humans N Engl J Med 352 2005 1959 1966
22. N. Fretellier, J.M. Idee, S. Guerret, C. Hollenbeck, D. Hartmann, W. Gonzalez, C. Robic, M. Port, and C. Corot Clinical, biological, and skin histopathologic effects of ionic macrocyclic and nonionic linear gadolinium chelates in a rat model of nephrogenic systemic fibrosis Invest Radiol 46 2011 85 93
23. T. Isakova, P. Wahl, G.S. Vargas, O.M. Gutierrez, J. Scialla, H. Xie, D. Appleby, L. Nessel, K. Bellovich, J. Chen, L. Hamm, C. Gadegbeku, E. Howritz, R.R. Townsend, C.A. Anderson, J.P. Lash, C.Y. Hsu, M.B. Leonard, and M. Wolf Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease Kidney Int 79 2011 1370 1378
24. C. Faul, A.P. Amaral, B. Oskouei, M.C. Hu, A. Sloan, T. Isakova, O.M. Gutierrez, R. Aguillon-Prada, J. Lincold, J.M. Hare, P. Mundel, A. Morales, J. Scialla, M. Fischer, E.Z. Soliman, J. Chen, A.S. Go, S.E. Rosas, L. Nessel, R.R. Townsend, H.I. Feldman, M. St John Sutton, A. Ojo, C. Gadegbeku, G.S. Di Marco, S. Reuter, D. Kentrup, K. Tiemann, M. Brand, J.A. Hill, O.W. Moe, O.M. Kuro, J.W. Kusek, M.G. Keane, and M. Wolf FGF23 induces left ventricular hypertrophy J Clin Invest 121 2011 4393 4408
25. M.R. Hayden, and D.J. Goldsmith Sodium thiosulfate: new hope for the treatment of calciphylaxis Semin Dial 23 2010 258 262
26. P. Yerram, G. Saab, P.R. Karuparthi, M.R. Hayden, and R. Khanna Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure-role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate Clin J Am Soc Nephrol 2 2007 258 263
27. S.E. Cowper Nephrogenic fibrosing dermopathy: the first 6 years Curr Opin Rheumatol 15 2003 785 790
28. V. Vakil, J.J. Sung, M. Piecychna, J.R. Crawford, P. Kuo, A.K. Abu-Alfa, S.E. Cowper, R. Bucala, and R.H. Gomer Gadolinium-containing magnetic resonance image contrast agent promotes fibrocyte differentiation J Magn Reson Imaging 30 2009 1284 1288
29. T.E. Quan, S.E. Cowper, and R. Bucala The role of circulating fibrocytes in fibrosis Curr Rheumatol Rep 8 2006 145 150
30. J. Rehman, J. Li, C.M. Orschell, and K.L. March Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors Circulation 107 2003 1164 1169
31. P. Romagnani, F. Annunziato, F. Liotta, E. Lazzeri, B. Mazzinghi, F. Frosali, L. Cosmi, L. Maggi, L. Lasagni, A. Scheffold, M. Kruger, S. Dimmeler, F. Marra, G. Gensini, E. Maggi, and S. Romagnani CD14+CD34 low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors Circ Res 97 2005 314 322
32. D. Cesselli, A.P. Beltrami, S. Rigo, N. Bergamin, F. D'Aurizio, R. Verardo, S. Piazza, E. Klaric, R. Fanin, B. Tofoletto, S. Marzinotto, L. Mariuzzi, N. Finato, M. Pandolfi, A. Leri, C. Schneider, C.A. Beltrami, and P. Anversa Multipotent progenitor cells are present in human peripheral blood Circ Res 104 2009 1225 1234
33. R. Abe, S.C. Donnelly, T. Peng, R. Bucala, and C.N. Metz Peripheral blood fibrocytes: differentiation pathway and migration to wound sites J Immunol 166 2001 7556 7562
34. J. Chesney, and R. Bucala Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis Curr Rheumatol Rep 2 2000 501 505
35. S.K. Mathai, M. Gulati, X. Peng, T.R. Russell, A.C. Shaw, A.N. Rubinowitz, L.A. Murray, J.M. Siner, D.E. Antin-Ozerkis, R.R. Montgomery, R.A.S. Reilkoff, R.J. Bucala, and E.L. Herzog Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype Lab Invest 90 2010 812 823
36. Y. Tintut, and L. Demer The hemosteoblast: friend or foe? Circ Res 108 2011 1038 1039
37. P. Joffe, H.S. Thomsen, and M. Meusel Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis Acta Radiol 5 1998 491 502
38. N.A. Guzman, W.Q. Ascari, K.R. Cutroneo, and R.J. Desnick Comparison between avian and human prolyl 4-hydroxylases: studies on the holomeric enzymes and their constituent subunits J Cell Biochem 48 1992 172 189
39. K. Otogawa, T. Ogawa, R. Shiga, K. Nakatani, K. Ikeda, Y. Nakajima, and N. Kawada Attenuation of acute and chronic liver injury in rats by iron-deficient diet Am J Physiol Regul Integr Comp Physiol 294 2008 R311 R320
40. Y. Takeda, H. Komaba, S. Goto, H. Fujii, M. Umezu, H. Hasegawa, A. Fujimori, M. Nishioka, S. Nishi, and M. Fukagawa Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients Am J Nephrol 33 2011 421 426
41. Y. Shimizu, Y. Tada, M. Yamauchi, T. Okamoto, H. Suzuki, N. Ito, S. Fukumoto, T. Sugimoto, and Fujita Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia Bone 45 2009 814 816
42. F. Vallelian, C.A. Schaer, T. Kaempfer, P. Gehrig, E. Duerst, G. Schoedon, and D.J. Schaer Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity Blood 116 2010 5347 5356
43. W.K. Kim, X. Alvarez, J. Fisher, B. Bronfin, S. Westmoreland, J. McLaurin, and K. Williams CD163 identifies perivascular macrophages in normal and viral encephalitic brains and potential precursors to perivascular macrophages in blood Am J Pathol 168 2006 822 834
44. J.A. Schroeder, C. Weingart, B. Coras, I. Hausser, S. Reinhold, M. Mack, V. Seybold, T. Vogt, B. Banas, F. Hofstaedter, and B.K. Kramer Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and end-stage renal disease Clin J Am Soc Nephrol 3 2008 968 975
45. D. Kroshinsky, J. Kay, and R.M. Nazarian Case records of the Massachusetts General Hospital. Case 37-2009. A 46-year-old woman with chronic renal failure, leg swelling, and skin changes N Engl J Med 361 2009 2166 2176
46. F.A. Mendoza, C.M. Artlett, N. Sandorfi, K. Latinis, S. Piera-Velasquez, and S.A. Jimenez Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature Semin Arthritis Rheum 35 2006 238 249
47. A.F. Taylor Osteoblastic glutamate receptor function regulates bone formation and resorption J Musculoskelet Neuronal Interact 2 2002 285 290
48. N. Fretellier, J.M. Idée, P. Bruneval, S. Guerret, F. Daubiné, G. Jestin, C. Factor, N. Poveda, A. Dencausse, F. Massicot, O. Laprévote, C. Mandet, N. Bouzian, M. Port, and C. Corot Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide Br J Pharmacol 165 2010 1151 1162
49. S. Swaminathan, I. Ahmed, J.T. McCarthy, R.C. Albright, M.R. Pittelkow, N.M. Caplice, M.D. Griffin, and N. Leung Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy Ann Intern Med 145 2006 234 235
50. S. Swaminathan, and S.V. Shah New insights into nephrogenic systemic fibrosis J Am Soc Nephrol 18 2007 2636 2643
51. T.A. Hope, W.A. High, P.E. LeBoit, B. Chaopathomkul, V.S. Rogut, R.J. Herfkens, and R.C. Brasch Nephrogenic systemic fibrosis in rats treated with erythropoietin and intravenous iron Radiology 253 2009 390 398
52. P. Robach, S. Recalcati, D. Girelli, C. Gelfi, N.J. Aachmann-Andersen, J.J. Thomsen, A.M. Norgaard, A. Alberghini, N. Campostrini, A. Castagna, A. Vigana, P. Santambrogio, T. Kempf, K.C. Wollert, S.P. Moutereau, C. Lundby, and G. Cairo Alterations of systemic and muscle iron metabolism in human subjects treated with low-dose recombinant erythropoietin Blood 113 2009 6707 6715
53. F.H. Bahlmann, K. de Groot, J.-M. Spandau, A.L. Landry, B. Hertel, T. Duckert, S.M. Boehm, J. Menne, H. Haller, and D. Floser Erythropoietin regulates endothelial progenitor cells Blood 103 2004 921 926
54. Y. Shiozawa, Y. Jung, A.M. Ziegler, E.A. Pedersen, J. Wang, Z. Wang, J. Song, J. Wang, C.H. Lee, S. Sud, K.J. Pienta, P.H. Krebsbach, and R.S. Taichman Erythropoietin couples hematopoiesis with bone formation PLoS One 5 2010 e10853